Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Hyperplasia × Levonorgestrel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Megestrol Acetate 5 Progestins 3 Medroxyprogesterone Acetate 3 Tirzepatide 2 Metformin 2 Blood Specimen Collection 2 Atorvastatin 2 semaglutide 1 exemestane 1 estradiol, norethindrone drug combination 1 Tamoxifen 1 Sampling Studies 1 Rosuvastatin Calcium 1 Resistance Training 1 Pterocarpus marsupium 1 Progesterone 1 Pharmacogenomic Variants 1 Observation 1 Nutrition Assessment 1 Magnetic Resonance Spectroscopy 1 Levonorgestrel 1 Intrauterine Devices 1 Immunohistochemistry 1 Hysteroscopy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Genetic Testing 1 Everolimus 1 Estrogen Replacement Therapy 1 Bupivacaine 1 3,5-dimethoxy-4'-hydroxystilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01686126 2024-08-28

feMMe

Queensland Centre for Gynaecological Cancer

Phase 2 Active not recruiting

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡